Cargando…
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
The ErbB tyrosine kinase receptor family has been shown to have an important role in tumorigenesis, and the expression of its receptor members is frequently deregulated in many types of solid tumors. Various drugs targeting these receptors have been approved for cancer treatment. Particularly, in br...
Autores principales: | De Cola, A, Volpe, S, Budani, M C, Ferracin, M, Lattanzio, R, Turdo, A, D'Agostino, D, Capone, E, Stassi, G, Todaro, M, Di Ilio, C, Sala, G, Piantelli, M, Negrini, M, Veronese, A, De Laurenzi, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650737/ https://www.ncbi.nlm.nih.gov/pubmed/26181203 http://dx.doi.org/10.1038/cddis.2015.192 |
Ejemplares similares
-
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer
por: Ghasemi, R, et al.
Publicado: (2014) -
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
por: Prasetyanti, Pramudita R., et al.
Publicado: (2015) -
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
por: Ciavardelli, D, et al.
Publicado: (2014) -
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)